Optimization, characterization and in vivo evaluation of mupirocin nanocrystals for topical administration

Eur J Pharm Sci. 2022 Sep 1:176:106251. doi: 10.1016/j.ejps.2022.106251. Epub 2022 Jul 3.

Abstract

Treatment of infectious skin conditions resulting from wounds and burns with topical antibiotics is challenging, particularly those caused by methicillin-resistant Staphylococcus aureus bacteria (MRSA). This is due to the formation of bacterial biofilms characterized by antimicrobial resistance. Mupirocin (MP), a widely used topical antibiotic, is active against gram-positive bacteria including MRSA. However, MP suffers from sub-optimal therapeutic efficacy due to its poor water-solubility and the significant rise in MP-resistant S. aureus. In this study, the physico-chemical characteristics of MP were modified through nanocrystallization to improve its therapeutic efficacy for the treatment of skin infections. Mupirocin-nanocrystals (MP-NC) were prepared using a nanoprecipitation technique and optimized using a D-optimal response surface design. The optimization of MP-NC produced ultra-small monodisperse spherical particles with a mean diameter of 70 nm and a polydispersity index of 0.2. The design resulted in two optimal MP-NC formulations that were evaluated by performing series of in vitro, ex vivo, microbiological, and in vivo studies. In-vitro results showed a 10-fold increase in the saturation solubility and a 9-fold increase in the dissolution rate of MP-NC. Ex vivo permeation studies, using pig ears skin, showed a 2-fold increase in the dermal deposition of MP-NC with the highest drug deposition occurring at 500-µm skin depth. Moreover, the optimal MP-NC formulations were lyophilized and incorporated into a 2% w/w cream. Microbiological studies revealed a 16-fold decrease in the minimum inhibitory concentration and the minimum bactericidal concentration of MP-NC. In vivo studies, using a rat excision burn wound model, demonstrated rapid and complete healing of infected burn wounds in rats treated with MP-NC cream in comparison to marketed Avoban ointment. Our results suggest that nanocrystallization of MP may provide an avenue through which higher levels of a topically applied MP can be permeated into the skin to reach relevant infectious areas and exert potential local antibacterial effects.

Keywords: Antibacterial activity; Dermal drug delivery; Ex vivo studies; Mupirocin; Nanocrystals; Rat excision burn wound infection model.

MeSH terms

  • Administration, Topical
  • Animals
  • Anti-Bacterial Agents
  • Burns* / drug therapy
  • Burns* / microbiology
  • Methicillin-Resistant Staphylococcus aureus*
  • Mupirocin / pharmacology
  • Nanoparticles*
  • Rats
  • Swine
  • Wound Infection* / drug therapy
  • Wound Infection* / microbiology

Substances

  • Anti-Bacterial Agents
  • Mupirocin